SCHEMBL5322672

SCHEMBL5322672

C=CCOC(=O)CONC1CN(C(=O)O)Nc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 9/20 0.37
NPSR1 Q6W5P4 1/20 0.36
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
FAAH O00519 2/20 0.33
CYP3A4 P08684 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MGLL Q99685 1/20 0.32
CHRM1 P11229 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5326263 0.90 CASP1 (0.33) CASP1CA1CA2CYP3A4CHRM1
SCHEMBL4862831 0.86 TDP1 (0.34) CASP1NPSR1PKMCA1CA2
SCHEMBL5318595 0.79 NPC1 (0.37) SMN1; SMN2GAAMAPTMAPK1
SCHEMBL14196718 0.69 NPSR1 (0.40) CASP1NPSR1PKMSMN1; SMN2CA1
SCHEMBL5320440 0.69 NPSR1 (0.40) CASP1NPSR1PKMSMN1; SMN2CA1
SCHEMBL5253676 0.68 ACE (0.36) SMN1; SMN2CA1CA2FAAHCYP3A4
SCHEMBL5188020 0.65 CYP19A1 (0.36) CHRM1MEN1KMT2A
SCHEMBL114035 0.64 CASP1 (0.56) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL1866841 0.64 CASP1 (0.56) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL5272076 0.62 CA1 (0.31) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537117-B1 BENZOTRIAZABICYCLIC DERIVATIVES AND USE THEREOF AS BETA-LACTAMASE INHIBITORS AND ANTI-BACTERIAL AGENTS AVENTIS PHARMA SA (FR) 2007-01-17 EP disclosed